Hoogenraad - Development of therapeutic antibodies against cachexia

Lab leader

Nicholas HoogenraadProfessor Nicholas Hoogenraad

Emeritus Professor AO, College of Science, Health and Engineering

View profile, publications and contact details

We have discovered a receptor that causes cancer cachexia a complication of cancer that affects up to 80% of patients with solid tumours and is responsible for around 25% of cancer deaths. We have produced monoclonal antibodies that block this condition, giving the prospect of a treatment. The signal for cachexia originates in the tumor leading to a search for the soluble factor released into the blood stream. We are in the process of humanizing the antibody in preparation for clinical trials.

Research area